Ritlecitinib and brepocitinib phase 2a randomized trial results review for alopecia areata treatment
Journal of the European Academy of Dermatology and Venereology | Jan 28, 2022
Real-life impact of the immunological tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study
Journal of the American Academy of Dermatology | Jan 27, 2022
Most read this week